Skip to main content
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
12.86
-1.56 (-10.82%)
At close: Apr 28, 2026, 4:00 PM EDT
13.00
+0.14 (1.09%)
After-hours: Apr 28, 2026, 6:45 PM EDT

Avalo Therapeutics Employees

Avalo Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 10 or 43.48% compared to the previous year.

Employees
33
Change (1Y)
10
Growth (1Y)
43.48%
Revenue / Employee
$1,788
Profits / Employee
-$2,371,485
Market Cap
343.55M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025331043.48%
Dec 31, 202423421.05%
Dec 31, 202319-1-5.00%
Dec 31, 202220-24-54.55%
Dec 31, 2021441341.94%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Related Stocks

Company Name Employees
Autolus Therapeutics 754
Rocket Pharmaceuticals 202
Puma Biotechnology 179
Enanta Pharmaceuticals 120
Silence Therapeutics 88
Lineage Cell Therapeutics 77
Immuneering 53
X4 Pharmaceuticals 45
Employee Rankings

AVTX News

More News